Prostate Cancer: IGF-1 signaling is strongly implicated in prostate cancer development and progression, including metastasis and therapy resistance
Pfizer's ambition in this space is further evidenced by its $10 billion acquisition of Metsera in 2025 , winning a bidding war against seven other companies
References 01954453 Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GJ, Williams R
Dihexa, a neuroregenerative peptide, has shown remarkable potential in promoting neuronal survival and their cognitive function in animal models
10.1016/j.vph.2015.05.005 Pubmed Abstract CrossRef Google Scholar View reference in article 15
Nakagaki K, et al